Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29687 | 182 | 27.5 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
26 | 2 | HEPATITIS C VIRUS//HEPATITIS C//HCV | 34145 |
29687 | 1 | HCV CORE ANTIGEN//HEPATITIS C VIRUS CORE ANTIGEN//HCV CORE ANTIGEN ASSAY | 182 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HCV CORE ANTIGEN | authKW | 3494548 | 15% | 77% | 27 |
2 | HEPATITIS C VIRUS CORE ANTIGEN | authKW | 1073771 | 4% | 80% | 8 |
3 | HCV CORE ANTIGEN ASSAY | authKW | 671109 | 2% | 100% | 4 |
4 | CORE ANTIGEN | authKW | 671093 | 7% | 33% | 12 |
5 | HCV AG | authKW | 536886 | 2% | 80% | 4 |
6 | HCV CORE AG | authKW | 503332 | 2% | 100% | 3 |
7 | HCVCAG | authKW | 503332 | 2% | 100% | 3 |
8 | HEPATITIS C CORE ANTIGEN | authKW | 377497 | 2% | 75% | 3 |
9 | CORE ANTIGEN DETECTION | authKW | 335555 | 1% | 100% | 2 |
10 | HEPATITIS C VIRUS NS3 ANTIGEN | authKW | 335555 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 2165 | 26% | 0% | 48 |
2 | Gastroenterology & Hepatology | 976 | 23% | 0% | 41 |
3 | Microbiology | 417 | 21% | 0% | 38 |
4 | Infectious Diseases | 298 | 13% | 0% | 23 |
5 | Hematology | 257 | 12% | 0% | 22 |
6 | Medical Laboratory Technology | 86 | 4% | 0% | 7 |
7 | Biochemical Research Methods | 43 | 6% | 0% | 11 |
8 | Biotechnology & Applied Microbiology | 21 | 6% | 0% | 11 |
9 | Medicine, General & Internal | 9 | 5% | 0% | 9 |
10 | Immunology | 7 | 5% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RICERCA AREA INFETTIVOL | 335555 | 1% | 100% | 2 |
2 | AIDS HEPATITIS ASSAY DEV | 167777 | 1% | 100% | 1 |
3 | BIOSTAT MED EDUC | 167777 | 1% | 100% | 1 |
4 | DEP HEMODIALYSIS | 167777 | 1% | 100% | 1 |
5 | GASTROENTEROLGY HEPATOL TROP MED | 167777 | 1% | 100% | 1 |
6 | GIM MICROBIOL BACTERIOL VIROL | 167777 | 1% | 100% | 1 |
7 | HEPATITIS STUDY | 167777 | 1% | 100% | 1 |
8 | MED HYG 123 KASUMI CHO MINAMI KU | 167777 | 1% | 100% | 1 |
9 | MED SANS FRONTIE ACCESS CAMPAIGN | 167777 | 1% | 100% | 1 |
10 | MICROBIOL TRANSFUS S | 167777 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL VIROLOGY | 9827 | 8% | 0% | 14 |
2 | JOURNAL OF CLINICAL MICROBIOLOGY | 3964 | 14% | 0% | 25 |
3 | JOURNAL OF VIRAL HEPATITIS | 3714 | 4% | 0% | 7 |
4 | JOURNAL OF MEDICAL VIROLOGY | 3167 | 7% | 0% | 12 |
5 | TRANSFUSION | 3148 | 7% | 0% | 12 |
6 | BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | 2437 | 2% | 0% | 4 |
7 | BEITRAGE ZUR INFUSIONSTHERAPIE/CONTRIBUTIONS TO INFUSION THERAPY | 2283 | 2% | 0% | 4 |
8 | JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY | 1665 | 1% | 0% | 2 |
9 | JOURNAL OF VIROLOGICAL METHODS | 1169 | 4% | 0% | 7 |
10 | VOX SANGUINIS | 1064 | 3% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HCV CORE ANTIGEN | 3494548 | 15% | 77% | 27 | Search HCV+CORE+ANTIGEN | Search HCV+CORE+ANTIGEN |
2 | HEPATITIS C VIRUS CORE ANTIGEN | 1073771 | 4% | 80% | 8 | Search HEPATITIS+C+VIRUS+CORE+ANTIGEN | Search HEPATITIS+C+VIRUS+CORE+ANTIGEN |
3 | HCV CORE ANTIGEN ASSAY | 671109 | 2% | 100% | 4 | Search HCV+CORE+ANTIGEN+ASSAY | Search HCV+CORE+ANTIGEN+ASSAY |
4 | CORE ANTIGEN | 671093 | 7% | 33% | 12 | Search CORE+ANTIGEN | Search CORE+ANTIGEN |
5 | HCV AG | 536886 | 2% | 80% | 4 | Search HCV+AG | Search HCV+AG |
6 | HCV CORE AG | 503332 | 2% | 100% | 3 | Search HCV+CORE+AG | Search HCV+CORE+AG |
7 | HCVCAG | 503332 | 2% | 100% | 3 | Search HCVCAG | Search HCVCAG |
8 | HEPATITIS C CORE ANTIGEN | 377497 | 2% | 75% | 3 | Search HEPATITIS+C+CORE+ANTIGEN | Search HEPATITIS+C+CORE+ANTIGEN |
9 | CORE ANTIGEN DETECTION | 335555 | 1% | 100% | 2 | Search CORE+ANTIGEN+DETECTION | Search CORE+ANTIGEN+DETECTION |
10 | HEPATITIS C VIRUS NS3 ANTIGEN | 335555 | 1% | 100% | 2 | Search HEPATITIS+C+VIRUS+NS3+ANTIGEN | Search HEPATITIS+C+VIRUS+NS3+ANTIGEN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOSSEINI-MOGHADDAM, SM , IRAN-POUR, E , ROTSTEIN, C , HUSAIN, S , LILLY, L , RENNER, E , MAZZULLI, T , (2012) HEPATITIS C CORE AG AND ITS CLINICAL APPLICABILITY: POTENTIAL ADVANTAGES AND DISADVANTAGES FOR DIAGNOSIS AND FOLLOW-UP?.REVIEWS IN MEDICAL VIROLOGY. VOL. 22. ISSUE 3. P. 156-165 | 59 | 65% | 10 |
2 | SEME, K , POLJAK, M , BABIC, DZ , MOCILNIK, T , VINCE, A , (2005) THE ROLE OF CORE ANTIGEN DETECTION IN MANAGEMENT OF HEPATITIS C: A CRITICAL REVIEW.JOURNAL OF CLINICAL VIROLOGY. VOL. 32. ISSUE 2. P. 92 -101 | 46 | 79% | 30 |
3 | FREIMAN, JM , TRAN, TM , SCHUMACHER, SG , WHITE, LF , ONGARELLO, S , COHN, J , EASTERBROOK, PJ , LINAS, BP , DENKINGER, CM , (2016) HEPATITIS C CORE ANTIGEN TESTING FOR DIAGNOSIS OF HEPATITIS C VIRUS INFECTION A SYSTEMATIC REVIEW AND META-ANALYSIS.ANNALS OF INTERNAL MEDICINE. VOL. 165. ISSUE 5. P. 345 -+ | 33 | 67% | 1 |
4 | MIXSON-HAYDEN, T , DAWSON, GJ , TESHALE, E , LE, T , CHENG, K , DROBENIUC, J , WARD, J , KAMILI, S , (2015) PERFORMANCE OF ARCHITECT HCV CORE ANTIGEN TEST WITH SPECIMENS FROM US PLASMA DONORS AND INJECTING DRUG USERS.JOURNAL OF CLINICAL VIROLOGY. VOL. 66. ISSUE . P. 15 -18 | 26 | 74% | 1 |
5 | GU, SJ , LIU, J , ZHANG, HJ , GU, BL , LAI, HJ , ZHOU, HL , HE, CQ , CHEN, YY , (2012) CORE ANTIGEN TESTS FOR HEPATITIS C VIRUS: A META-ANALYSIS.MOLECULAR BIOLOGY REPORTS. VOL. 39. ISSUE 8. P. 8197-8208 | 20 | 83% | 5 |
6 | LAPERCHE, S , NUBLING, CM , STRAMER, SL , BROJER, E , GRABARCZYK, P , YOSHIZAWA, H , KALIBATAS, V , EL ELKYABI, M , MOFTAH, F , GIRAULT, A , ET AL (2015) SENSITIVITY OF HEPATITIS C VIRUS CORE ANTIGEN AND ANTIBODY COMBINATION ASSAYS IN A GLOBAL PANEL OF WINDOW PERIOD SAMPLES.TRANSFUSION. VOL. 55. ISSUE 10. P. 2489 -2498 | 23 | 68% | 1 |
7 | DAWSON, GJ , (2012) THE POTENTIAL ROLE OF HCV CORE ANTIGEN TESTING IN DIAGNOSING HCV INFECTION.ANTIVIRAL THERAPY. VOL. 17. ISSUE 7. P. 1431-1435 | 18 | 90% | 8 |
8 | PARK, Y , LEE, JH , KIM, BS , KIM, DY , HAN, KH , KIM, HS , (2010) NEW AUTOMATED HEPATITIS C VIRUS (HCV) CORE ANTIGEN ASSAY AS AN ALTERNATIVE TO REAL-TIME PCR FOR HCV RNA QUANTIFICATION.JOURNAL OF CLINICAL MICROBIOLOGY. VOL. 48. ISSUE 6. P. 2253-2256 | 16 | 89% | 46 |
9 | ERGUNAY, K , SENER, B , ALP, A , KARAKAYA, J , HASCELIK, G , (2011) UTILITY OF A COMMERCIAL QUANTITATIVE HEPATITIS C VIRUS CORE ANTIGEN ASSAY IN A DIAGNOSTIC LABORATORY SETTING.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. VOL. 70. ISSUE 4. P. 486-491 | 21 | 72% | 8 |
10 | KARABAY, O , OGUTLU, A , ANKARALI, H , OZDEMIR, F , KARABAY, M , GOZDAS, HT , (2014) COMPARISON OF HCV RNA AND HCV CORE ANTIGEN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS.ACTA MEDICA MEDITERRANEA. VOL. 30. ISSUE 5. P. 1025 -1028 | 15 | 94% | 0 |
Classes with closest relation at Level 1 |